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OBJECTIVES The goal of this study was to examine long-term trends in the incidence, in-hospital and
long-term mortality patterns in patients with an initial non-Q-wave myocardial infarction
(NQWMI) as compared with those with an initial Q-wave myocardial infarction (QWMI).
BACKGROUND Limited data are available describing trends in the incidence and mortality from an initial
QWMI and NQWMI from a multi-hospital community-wide perspective.
METHODS Our study was an observational study of 5,832 metropolitan Worcester, Massachusetts
residents (1990 census 5 437,000) hospitalized with validated initial acute MI in all greater
Worcester hospitals during 11 annual periods between 1975 and 1997.
RESULTS The incidence of QWMI progressively decreased between 1975/78 (incidence rate 5
171/100,000 population) and 1997 (101/100,000 population). In contrast, the incidence of
NQWMI progressively increased between 1975/78 (62/100,000 population) and 1997
(131/100,000 population). Hospital death rates were 19.5% for patients with QWMI and
12.5% for those with NQWMI. After controlling for various covariates, patients with
QWMI remained at significantly increased risk for hospital mortality (adjusted odds ratio 5
1.63; 95% confidence interval: 1.35, 1.97). While the hospital mortality of QWMI has
progressively declined over time (1975/78 5 24%; 1997 5 14%), the in-hospital mortality for
NQWMI has remained the same (1975/78 5 12%; 1997 5 12%). These trends remained
after adjusting for potentially confounding prognostic factors. The multivariable adjusted
two-year mortality after hospital discharge declined over time for patients with QWMI and
NQWMI.
CONCLUSIONS Despite impressive declines in the incidence, in-hospital and long-term mortality associated
with QWMI, NQWMI is increasing in frequency and has the same in-hospital mortality
now as it did 22 years ago. (J Am Coll Cardiol 2001;37:1571–80) © 2001 by the American
College of Cardiology
Coronary heart disease is often considered as a spectrum of
disease states ranging from silent myocardial ischemia on
one extreme to acute myocardial infarction (AMI) at the
other extreme. Unstable angina and non-Q-wave myocar-
dial infarction (NQWMI) occupy the midpoint of this
pathophysiologic spectrum (1). Rupture of an atheroscle-
rotic coronary plaque with resultant thrombus formation is
a common pathophysiological feature of the acute coronary
syndromes of unstable angina, NQWMI and Q-wave MI
(QWMI) (2). Despite these common features, the results of
several studies suggest that the short- and long-term out-
comes of these conditions differ (3,4). These differences may
relate to the degree of intracoronary thrombosis and vaso-
spasm, duration of the acute thrombotic occlusion and
ability of the underlying plaque disruption to heal (4).
Differences in these outcomes may also relate to differences
in study design, in the characteristics of the comparative
study samples and to control (or lack thereof) for other
demographic or clinical factors that may affect in-hospital
and post-discharge outcomes of patients with QWMI and
NQWMI. Hospital mortality appears to be greater for
patients with QWMI than it is for those with NQWMI (5).
On the other hand, the rates of reinfarction, recurrent
angina and long-term mortality appear to be higher for
hospital survivors of NQWMI (3).
Given the magnitude of coronary heart disease in the
U.S., it remains of importance to examine differences in the
incidence, in-hospital and long-term outcomes of patients
with NQWMI compared with those with QWMI and to
determine whether trends in patterns of infarction have
changed over time. Using data from the population-based
Worcester Heart Attack study, we examined trends in the
incidence, hospital and long-term mortality of 5,832 resi-
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dents of the Worcester, Massachusetts metropolitan area
who had been admitted to all greater Worcester hospitals
between 1975 and 1997 with confirmed AMI. This 22-year
interval spans the periods before and after the establishment
of more effective cardiac therapies used in the management
of patients with AMI.
METHODS
The population under study consisted of residents of the
Worcester, Massachusetts, metropolitan area hospitalized
with a discharge diagnosis of AMI in all acute care general
hospitals in the Worcester Standard Metropolitan Statisti-
cal Area (SMSA) (1990 census estimate 5 437,000) during
1975, 1978, 1981, 1984, 1986, 1988, 1990, 1991, 1993,
1995 and 1997 (6–8). Sixteen teaching and community
hospitals were included in this study from the mid 1970s
through the late 1980s, while fewer hospitals were included
thereafter due to hospital closures, mergers or conversion to
chronic care facilities. The medical records of greater
Worcester residents with a discharge diagnosis of AMI
from these hospitals were individually reviewed and vali-
dated by physician and nurse abstractors as previously
described (6–8).
The criteria for diagnosis of AMI included at least two of
the following: 1) clinical history of prolonged chest pain; 2)
serum enzyme elevations in excess of the upper limit of
normal as specified by the laboratory at each hospital; and 3)
serial electrocardiogram (ECG) tracings during hospitaliza-
tion showing changes in the ST segment or Q-waves. A
diagnosis of QWMI was accepted when Q-waves with a
duration of 0.04 s or more and an amplitude equal to or
greater than 25% of the R wave in that lead, as well as a
typical pattern of evolutionary changes in the ST segment
and T waves, appeared in two or more contiguous leads in
serial ECGs with or without a typical clinical history or
serum enzyme elevations. A diagnosis of NQWMI was
accepted when, in the absence of Q-waves, ischemic ST
segment and T wave changes persisted for at least 24 h in
the presence of enzyme elevations or a typical history. These
changes consisted of either ST segment depression $1 mm
(with or without symmetrical T wave inversion) or symmet-
rical T wave inversion alone. ST segment elevation AMI
was classified as Q-wave or non-Q-wave based on the
presence or absence of Q-waves 24 h after hospital admis-
sion. These ECGs were interpreted by a trained team of
physician and nurse reviewers who received extensive train-
ing in the review of ECGs and medical records. Quality
control activities on the interpretation of ECGs and ab-
straction of information from patients’ charts were routinely
incorporated over the course of the study. Patients with
confirmed AMI who died within minutes of hospital
admission, or who died shortly thereafter without the
appearance of Q-waves in their ECGs, were classified as
NQWMI. Troponin assays were not used to diagnose AMI.
Cases of perioperative AMI or those secondary to other
noncardiac conditions were not included. The complica-
tions of AMI were assessed on the basis of information
available from the clinical charts (6–8). The 11 study
periods were categorized into five periods of two years each
and one single year period to make subsequent data analyses
more interpretable.
Data collection. The hospital records of patients with
validated AMI were abstracted for demographic and clinical
data including age, gender, medical history, complications
during hospitalization, ECG findings and use of diagnostic
procedures and therapeutic approaches. Records of previous
hospitalizations for coronary heart disease were reviewed
where available when the review of the hospital chart
indicated that the present hospitalization was not the first
for coronary heart disease. This was done to identify initial
cases of AMI that constituted the sample of the present
report. Patients with ECG changes indicative of prior MI
(old Q-waves on ECG) or prior documented MI (con-
firmed by medical records of prior hospitalizations) were
excluded from this study. Approaches used to ascertain
survival status after hospital discharge included a review of
records for additional hospitalizations and a statewide and
national search of death certificates for residents of the
Worcester SMSA.
Data analysis. Differences in the distribution of demo-
graphic, clinical and treatment characteristics in hospital-
ized patients according to AMI type (Q-wave vs. non-Q-
wave) were examined by use of chi-square tests of statistical
significance for discrete variables and t tests for continuous
variables. Analysis of variance was used to examine the
significance of differences in average age of patients with
QWMI and NQWMI over time. The simultaneous effects
of several potentially confounding variables that might
influence in-hospital survival and two-year mortality after
hospital discharge were accounted for by means of a logistic
multiple regression technique. The variables controlled for
included age, gender, a history of angina, diabetes, hyper-
tension or stroke, AMI location and occurrence of conges-
tive heart failure or cardiogenic shock during admission.
These variables were controlled for on the basis of their
previously known associations with mortality after AMI and
because there were differences in the distribution of these
factors between patients with QWMI and NQWMI. A life
table approach was used to examine the association of
QWMI and NQWMI to long-term survivorship. The Cox
proportional hazards regression model was used to examine
the association of AMI type to long-term prognosis while
Abbreviations and Acronyms
AMI 5 acute myocardial infarction
CI 5 confidence interval
ECG 5 electrocardiogram
MI 5 myocardial infarction
NQWMI 5 non-Q-wave myocardial infarction
QWMI 5 Q-wave myocardial infarction
SMSA 5 Standard Metropolitan Statistical Area
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controlling for potentially confounding prognostic factors
and duration of follow-up.
RESULTS
Characteristics of patients with initial QWMI or
NQWMI. Over the 22-year study period (Table 1) and
during each study interval (Table 2), patients who developed
an initial NQWMI were significantly older and more likely
to be women than those who developed an initial QWMI.
The mean age and the percentage of women in patients
developing either QWMI or NQWMI increased over time
(Table 2). Patients with NQWMI were more likely to
include those with a history of angina, diabetes, hyperten-
sion or stroke, and differences in the prevalence rates of
these comorbidities between patients with NQWMI and
QWMI persisted over time. Overall, patients with
NQWMI were more likely to receive aspirin, beta-
adrenergic blocking agents and calcium channel blockers
during the acute hospitalization (Table 1). Consistent and
increasing trends in the use of beta-blockers and
angiotensin-converting enzyme inhibitors and declines over
time in the use of calcium channel blockers were observed
(Table 2). Patients with QWMI were significantly more
likely to be treated with thrombolytic agents overall and
during each study period. As expected, we observed marked
increases over time in the use of thrombolytic agents in
patients with QWMI but not NQWMI (Table 2). Overall,
patients with QWMI were more likely to receive a percu-
taneous coronary intervention but less likely to undergo
coronary artery bypass grafting during the index hospital-
ization (Table 1). However, the absolute magnitude of the
difference between our respective comparison groups in the
receipt of these procedures was small. The proportion of
patients with AMI undergoing a percutaneous coronary
intervention increased over time, though this increase was
greater in patients with QWMI than it was in patients with
NQWMI (Table 2).
Patients with QWMI were more likely to develop con-
gestive heart failure and cardiogenic shock during the acute
hospitalization overall as well as during each of the periods
under study (Tables 1 and 2).
Temporal trends in the incidence rates of initial QWMI
or NQWMI. The incidence rates of QWMI progressively
declined over the 22 years under study (Fig. 1). In contrast,
the incidence rates of NQWMI progressively increased over
time (Fig. 1).
A multivariable adjusted regression analysis was used to
examine trends over time in the likelihood of developing
NQWMI while controlling for previously described vari-
ables that differed between the respective comparison
groups. Relative to the referent period of 1975/78 (odds
ratio 5 1.0), patients hospitalized in 1981/84, 1986/88,
1990/91, 1993/95 and 1997 were at 1.35 (95% confidence
interval [CI]: 1.11, 1.63), 1.75 (95% CI: 1.44, 2.13), 2.09
(95% CI: 1.72, 2.53), 2.91 (95% CI: 2.41, 3.51) and 3.38
(95% CI: 2.72, 4.19) times greater likelihood of developing
non-Q-wave AMI, respectively.
The rapid opening of occluded coronary arteries by
administration of thrombolytic therapy in patients with
ST-segment elevation MI may lead to an increase in the
occurrence of NQWMI and a corresponding decrease in the
incidence of QWMI by halting or attenuating myocardial
damage and preventing the development of Q-waves on the
ECG. Therefore, we carried out an additional analysis of
trends in the incidence of NQWMI after we excluded
patients who received thrombolytic therapy during hospi-
talization. Despite excluding these patients, the incidence of
NQWMI consistently increased over time. For example, the
incidence of NQWMI (per 100,000 population) increased
from 62 in 1975/78 to 68 in 1986/88, 88 in 1993/95 and
117 in 1997.
Hospital death rates according to type of AMI. Overall,
hospital death rates were significantly higher for patients
with QWMI (19.5%) as compared with those with
NQWMI (12.5%) (p , 0.001). After controlling for pre-
viously described demographic and clinical covariates, as
well as time period of hospitalization, patients with QWMI
remained at significantly increased risk for hospital mortal-
ity (adjusted odds of dying 5 1.63; 95% CI: 1.35, 1.97).
While the unadjusted hospital mortality rates of QWMI
have progressively declined over the 22-year study period,
the hospital mortality rates for NQWMI have remained the
Table 1. Distribution of Selected Characteristics in Patients
Presenting With Initial Q-Wave or Non-Q-Wave Myocardial
Infarction: Worcester Heart Attack Study
Characteristics
Q-Wave
Myocardial
Infarction
(n 5 3,396)
Non-Q-Wave
Myocardial
Infarction
(n 5 2,436)
p
Value
Mean age (yrs) 65 69 , 0.001
Age (yrs) (%)
,55 23 15
55–64 24 19 , 0.001
65–74 26 28
$75 27 38
Men (%) 63 54 , 0.001
Medical history (%)
Angina 16 23 , 0.001
Diabetes 21 23 , 0.007
Hypertension 47 52 , 0.001
Stroke 6 9 , 0.001
Medication (%)
ACE inhibitor 30 27 NS
Antiplatelet agent 44 55 , 0.001
Beta-blocker 49 55 , 0.001
Calcium channel blocker 38 49 , 0.001
Thrombolytic agent 21 10 , 0.001
Procedures (%)
PCI 7 5 , 0.001
CABG 2 3 , 0.001
Complications (%)
Congestive heart failure 36 32 , 0.001
Shock 8 4 , 0.001
ACE 5 angiotensin-converting enzyme; CABG 5 coronary artery bypass grafting;
NS 5 nonsignificant (p . 0.05); PCI 5 percutaneous coronary intervention.
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same (Fig. 2). After adjusting for demographic, medical
history and clinical characteristics, there was a consistent
and significant decline in the risk of dying for patients with
initial QWMI (Table 3). In contrast, the multivariable
adjusted odds of dying for patients with initial NQWMI
were inconsistent over time and did not change significantly
during the most recent study periods (Table 3).
Trends in long-term survival after hospital discharge.
Overall, the long-term survival rates for patients with
QWMI were 91%, 86%, 75% and 56% at 1, 2, 5 and 10
years after hospital discharge, respectively. Corresponding
survival rates were 85%, 80%, 65% and 47% for patients
with NQWMI (Fig. 3).
A Cox proportional hazards regression analysis confirmed
the lower overall, albeit nonsignificant, long-term mortality
for patients with QWMI, as compared with those with
NQWMI, after controlling for other prognostic character-
istics (adjusted odds ratio 5 0.92, 95% CI: 0.84, 1.01).
Since mortality after hospital discharge for AMI is
greatest within the first two years and because of the
availability of two-year follow-up data for each cohort (with
the exception of patients hospitalized in 1997) we examined
trends in two-year mortality according to type of AMI for
patients discharged between 1975 and 1995. Unadjusted
two-year mortality rates after hospital discharge decreased
for patients with QWMI (Fig. 4A) but increased for those
with NQWMI (Fig. 4B). After simultaneously adjusting for
various prognostic factors, the multivariable adjusted two-
year mortality rates decreased significantly over time for
patients with QWMI. This was particularly evident from
the mid-1980s on when thrombolytic therapy and other
effective cardiac medications were increasingly utilized in
Figure 1. Temporal trends in the incidence rates of initial Q-wave myocardial infarction and non-Q-wave myocardial infarction: Worcester Heart Attack
study.
Figure 2. Temporal trends in the hospital case fatality rates of Q-wave myocardial infarction (MI) and non-Q-wave MI: Worcester Heart Attack study.
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these patients. The two-year mortality rates for patients
with initial NQWMI also declined over time, albeit to a
nonsignificant extent (Table 4).
DISCUSSION
The results of this population-based study carried out
among residents of a large representative Northeastern
metropolitan area demonstrate that the incidence of initial
NQWMI has increased markedly over the 22-year period
examined. While patients with QWMI experienced signif-
icantly higher overall hospital death rates than those with
NQWMI, in-hospital and post-discharge mortality de-
creased in patients with QWMI. In contrast, hospital
mortality for patients with NQWMI remained essentially
the same over this two-decade long period, while their
post-discharge survival improved, particularly during recent
study years. The use of medications proven to be effective in
the management of patients with AMI increased over time
in patients with QWMI and NQWMI. However, the
greatest increases in the use of these agents were seen in
patients with QWMI, which may have partially contributed
to the encouraging trends in prognosis observed in these
patients.
A recent editorial (9) suggested that there is no mean-
ingful pathophysiological distinction between QWMI and
NQWMI. Phibbs et al. (9) note flaws in previous studies
suggesting that the outcomes of patients with QWMI and
NQWMI were different. These authors suggested that all
studies examining differences in the outcomes of patients
with QWMI and NQWMI should include only initial
AMIs and control for possible differences in age, infarct
location and size. In our study, we controlled for these and
other variables. In addition, we have the advantage of being
population-based (in contrast with treatment-based) with
long-term follow-up over a 22-year study period. Therefore,
the results of our study suggest that QWMI is, indeed, a
distinctive pathophysiologic entity from NQWMI.
Incidence of NQWMI. Similar to this study, several
previous studies (10–12), including an earlier report from
the Worcester Heart Attack study (13), suggested an
increase in the incidence of NQWMI over varying periods
preceding the thrombolytic era. The increased incidence of
NQWMI observed in our study may be related to a more
frequent use of the ECG for diagnostic purposes or more
frequent assaying for cardiac enzymes over the periods
under study. However, we do not have data on the fre-
quency of ECG or serial cardiac enzyme use. Our methods
of ascertainment and diagnosis of cases of AMI remained
the same over time. Thus, while routine use of more
sensitive markers of myocardial necrosis has increased the
detection of AMI in other studies (14,15), it is not respon-
sible for the increased incidence of NQWMI seen in this
study. Changes in the natural history of AMI due to a
modification of coronary risk factors, reduction in prehos-
pital delay after the onset of symptoms and improvements in
access to and advances in medical care may also have
contributed to the trends seen in our study. Indeed, marked
changes over time in management practices of patients with
AMI have occurred in our study population (16,17).
The use of early reperfusion strategies for ST segment
elevation MI has been suggested to play a role in increasing
the development of NQWMIs by converting QWMI to
NQWMIs (4). Ten to fifteen percent of patients with
NQWMI in our study received thrombolytic agents, which
is slightly lower than the rates of utilization of these agents
seen in other studies (18–24). These usage rates reflect the
Table 3. Multivariable-Adjusted Risk of Dying During Hospitalization From Initial Q-Wave or
Non-Q-Wave Myocardial Infarction
Study
Period
Q-Wave Myocardial Infarction Non-Q-Wave Myocardial Infarction
Multivariable-Adjusted
Risk of Dying* 95% CI
Multivariable-Adjusted
Risk of Dying* 95% CI
1975/1978 1.0† 1.0†
1981/1984 0.72 0.53, 0.99 0.48 0.24, 0.93
1986/1988 0.65 0.47, 0.92 1.31 0.74, 2.31
1990/1991 0.42 0.29, 0.60 1.25 0.72, 2.20
1993/1995 0.30 0.20, 0.43 0.89 0.51, 1.57
1997 0.27 0.16, 0.43 0.92 0.51, 1.68
*Adjusted for age, gender, history of angina, diabetes, hypertension stroke, AMI location and occurrence of congestive heart
failure or cardiogenic shock during the acute hospitalization. †Referent category.
CI 5 confidence interval.
Figure 3. Long-term mortality after hospital discharge for Q-wave myo-
cardial infarction and non-Q-wave myocardial infarction: Worcester Heart
Attack study. Solid square 5 Q-wave; solid circle 5 non-Q-wave.
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multi-hospital, community-based perspective of this study.
However, in our study, the incidence of NQWMI began
increasing before the more widespread use of thrombolytic
agents in the late 1980s to early 1990s. In addition, when we
carried out a subgroup analysis excluding patients who
received thrombolytic therapy, trends toward an increased
incidence of NQWMI remained. Thus, conversion of
QWMI to NQWMIs by reperfusion therapy can only
partially explain the increased incidence of NQWMI seen in
our study.
Other factors in addition to the more widespread use of
thrombolytic agents may also have contributed to the
observed increases in NQWMI. For example, use of aspirin
has been shown to limit infarct size and reduce the risk of
developing QWMI in patients not receiving thrombolytic
therapy (25,26). Marked increases over time in the use of
Figure 4. Temporal trends in two-year survival rates after hospital discharge for (A) Q-wave myocardial infarction (MI) and (B) non-Q-wave MI:
Worcester Heart Attack study.
Table 4. Multivariable-Adjusted Risk of Dying Within Two Years of Hospital Discharge From
Initial Q-Wave or Non-Q-Wave Myocardial Infarction
Study
Period
Q-Wave Myocardial Infarction Non-Q-Wave Myocardial Infarction
Multivariable-Adjusted
Risk of Dying* 95% CI
Multivariable-Adjusted
Risk of Dying* 95% CI
1975/1978 1.0† 1.0†
1981/1984 1.13 0.88, 1.56 0.81 0.52, 1.28
1986/1988 0.67 0.46, 0.97 0.74 0.47, 1.18
1990/1991 0.86 0.61, 1.22 0.72 0.46, 1.12
1993/1995 0.46 0.31, 0.67 0.65 0.42, 1.00
*Adjusted for age, gender, history of angina, diabetes, hypertension stroke, AMI location and occurrence of congestive heart
failure or cardiogenic shock during the acute hospitalization. †Referent category.
CI 5 confidence interval.
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aspirin were observed in our study. In addition, the increas-
ing use of other medications or treatment strategies over the
past 22 years may have influenced the incidence rates of
NQWMI (8,27).
National (28,29) and population-based (30,31) changes
in the commonly accepted risk factors for coronary artery
disease, including cigarette smoking and elevated serum
cholesterol and blood pressure levels, have demonstrated
consistent improvements over the past several decades.
These improvements may be associated with an increase in
the incidence of NQWMI or “milder” MIs. Unfortunately,
changes over time in the major and less well-established risk
factors for AMI are not monitored as part of our surveil-
lance activities of the Worcester Heart Attack study. There-
fore, we cannot ascertain the effects of risk factor improve-
ments on the incidence of NQWMI in this study.
Given the multitude of potential reasons for the increased
incidence of NQWMI demonstrated in our study, we
cannot know for certain which of the above factors, if any,
is responsible for this increased incidence.
Hospital mortality. In a review of data from studies carried
out between 1962 and 1993 (5), initial NQWMI was
associated with a hospital death rate of 6.8%, while QWMI
was associated with a hospital case-fatality rate of 15.8%.
Our study results confirm the higher overall hospital death
rates for patients with initial QWMI over the past two
decades.
Despite the adverse overall impact of QWMI on hospital
prognosis, marked declines in hospital death rates over time
were observed in patients with QWMI, whereas patients
with NQWMI experienced little to no change in hospital
mortality. As a result of these trends, hospital mortality for
patients with QWMI was similar to that for patients with
NQWMI in 1997. While the reasons for the encouraging
decline in mortality for patients with QWMI are unknown,
this reduction likely reflects the increased use of therapies
shown to be effective in the management of ST segment
elevation MI (8,32), including use of aspirin (33), beta-
blockers (34), acute reperfusion strategies (thrombolytic
therapy and percutaneous coronary interventions) (35–38)
and angiotensin-converting enzyme inhibitors. The 70%
reduction in the multivariable adjusted risk of dying during
the acute hospitalization for patients with QWMI found
in our study is similar to the 60% reduction seen in Registre
Gironi del COR (REGICOR) (39), a community-based
study of patients with initial QWMI hospitalized in Ge-
rona, Spain, between 1978 and 1993. Despite their signif-
icantly lower overall in-hospital mortality, targeted inter-
vention efforts remain needed for patients with NQWMI
given their lack of improvement over time in hospital
survival between 1975 and 1997. The encouraging results
observed with the use of new therapies such as platelet
GPIIb-IIIa antagonists (40) for the treatment of acute
coronary syndromes may enhance the short- and long-term
outlook of patients with NQWMI.
Long-term mortality. We (8) and others (32) have re-
cently reported encouraging trends in the long-term survival
of patients discharged from hospitals after AMI. The results
of this study suggest that this benefit is primarily seen in
patients with QWMI, although a trend towards improved
two-year survival after NQWMI was seen during the most
recent study periods. This study is consistent with others (5)
that demonstrate a higher long-term mortality for patients
with NQWMI compared with those with QWMI.
Patients discharged from the hospital after NQWMI
have been shown to have more jeopardized myocardium and
a greater concurrent risk of both recurrent ischemia and
reinfarction (4,41). Therefore, the improving trends ob-
served in two-year survival rates for patients with QWMI
and NQWMI probably reflect improved therapeutic efforts
to limit the extent of acute myocardial necrosis, reduce
further ischemic burdens and improve left ventricular func-
tion.
The use of a survivor cohort (Fig. 4) has implications for
interpreting differences in long-term mortality risk. Higher
in-hospital mortality for patients with QWMI removes
potentially high-risk patients from the post-discharge co-
hort. Similarly, fewer in-hospital deaths in patients with
NQWMI potentially increase the proportion of higher risk
patients who are available for long-term follow-up and their
associated risk for post-discharge outcomes. These possible
caveats need to be kept in mind when interpreting our
long-term mortality data.
Study strengths and limitations. This study was carried
out among residents of a well-defined metropolitan area
whose sociodemographic and economic characteristics re-
flect those of the U.S. population as a whole, with the
exception of race (the vast majority of residents of the
Worcester metropolitan area are white). The strengths of
this study are its large sample of men and women with
validated AMI and its population-based design. Because of
the nonrandomized observational nature of this study, we
did not control for the use of interventional procedures or
medical therapies in examining differences in hospital and
post-discharge survival in patients with QWMI or
NQWMI. While trends in the incidence and case-fatality
rates of Q-wave or NQWMI may be affected by the use of
these management approaches, we did not control for the
use of these therapies in additional regression analyses. The
nonrandomized nature of this study makes analysis of the
influence of medical therapies on incidence and case-fatality
rates of QWMI and NQWMI difficult to interpret.
Due to our methods of data abstraction, we did not
collect data on lifestyle practices or treatment approaches
(including revascularization procedures) used by patients
after leaving the hospital and, therefore, are unable to
examine the impact of these interventions on post-discharge
survival. We were also unable to determine whether these
treatment approaches were differentially applied according
to type of AMI or if competing causes of death differed
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between patients with QWMI and NQWMI after hospital
discharge.
Conclusions. While the trends of improved hospital and
post-discharge outcomes for patients with QWMI are
encouraging, the lack of improvement over the past 22 years
in the hospital survival rates for patients with NQWMI is
disappointing. This study underscores the evidence from
previous studies that QWMI is associated with greater
in-hospital mortality but lower post-hospital mortality than
NQWMI, despite the more aggressive approaches to in-
hospital management of AMI. Moreover, our data suggest
that NQWMIs are likely to continue to account for an
increasing proportion of all AMIs. Thus, investigation into
the prevention and treatment of NQWMI remains of
considerable importance.
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